Brain cancer fight: testing combo therapy for tough lung cancer cases
NCT ID NCT05746481
Summary
This study tested whether a combination of two immunotherapy drugs, tiragolumab and atezolizumab, could help control non-small cell lung cancer that had spread to the brain. It was for patients whose brain tumors were not yet causing symptoms and had not been treated. The main goal was to see if this drug combo could delay or prevent the need for brain radiation therapy. The trial was terminated early after enrolling only 3 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
Conditions
Explore the condition pages connected to this study.